Veradigm | MDRX - Выручка от реализации





Продажи Изменить Дата
Alcidion AUD 23.15M 5.51M 2025-06
Ambu A/S DKK 1.56B 90M 2025-12
Amplifon EUR 652M 88.7M 2025-12
Cardinal Health USD 65.63B 1.63B 2025-12
Centene USD 49.73B 40M 2025-12
Charles River Laboratories USD 994.2M 5.8M 2025-12
Cigna USD 72.47B 2.77B 2025-12
Computer Programs Systems USD 83.83M 900K 2024-09
Convatec Group USD 1.26B 80M 2025-12
CVS Health USD 105.7B 2.8B 2025-12
Diasorin EUR 280M 26M 2025-09
Elevance Health USD 49.3B 790M 2025-12
General Electric Aerospace USD 11.87B 560M 2025-12
Gulf Medical Proj AED 213.77M 28.4M 2025-12
Humana USD 32.52B 130M 2025-12
IQVIA Holdings USD 4.36B 260M 2025-12
Laboratory Of America USD 3.52B 40M 2025-12
Maximus USD 1.35B 30M 2025-12
McKesson USD 106.16B 3.01B 2025-12
Med Life RON 787.96M 8.36M 2025-09
Molina Healthcare USD 11.38B 100M 2025-12
Omnicell USD 314M 3.37M 2025-12
Oriola-kd EUR 463.3M 30.6M 2025-09
Owens Minor USD 697.26M 15.36M 2025-09
Quest Diagnostics USD 2.81B 10M 2025-12
Rede D'or Sao Luiz BRL 14.6B 480M 2025-09
Siemens Healthineers EUR 5.4B 920M 2025-12
Sonova Holding CHF 1.82B 216.8M 2025-12
Supermax Corporation Bhd MYR 205.56M 50.82M 2025-09
UnitedHealth USD 113.2B 0 2025-12
Veeva Systems USD 835.95M 24.72M 2025-12
Veradigm USD 151.9M 1M 2022-09
Xerox USD 2.03B 70M 2025-12